[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $85114b Crypto project sees positive social sentiment. Market volatility causes price fluctuations. ### About $85114b A cryptocurrency project. ### Engagements: XXX [#](/topic/$85114b/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$85114b/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **1-Year High**: XXXXX on 2025-10-15 **1-Year Low**: XXX on 2025-10-16 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$85114b/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$85114b/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1-Year High**: X on 2025-10-15 **1-Year Low**: X on 2025-10-15 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$85114b/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$85114b/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $85114b in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1-Year High**: X on 2025-10-15 **1-Year Low**: X on 2025-10-15 ### Sentiment: XXX% [#](/topic/$85114b/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$85114b/time-series/sentiment.tsv) **Current Value**: XXX% **Daily Average**: XXX% **1-Year High**: XXX% on 2025-10-15 **1-Year Low**: XXX% on 2025-10-15 **Most Supportive Themes** - **Positive Sentiment:** (60%) Community members are expressing optimism about the project's future. **Most Critical Themes** - **Market Volatility:** (20%) Concerns about the overall market conditions and their impact on the project. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XX | XX% | X | X% | | | | | | | | | | Total | XXX | XX% | XX | XX% | X | X% | **Top assets mentioned** In the posts about $85114b in the last XX hours [uniQure N.V. (QURE)](/topic/$qure) [Novartis AG (NVS)](/topic/novartis) **Top topics mentioned** In the posts about $85114b in the last XX hours [$qure](/topic/$qure), [$clpt](/topic/$clpt), [upside](/topic/upside), [novartis](/topic/novartis), [$novnsw](/topic/$novnsw), [stocks healthcare](/topic/stocks-healthcare), [over the](/topic/over-the), [half of](/topic/half-of), [acquisition](/topic/acquisition), [power of](/topic/power-of), [jordan](/topic/jordan), [$25b](/topic/$25b), [100k](/topic/100k), [breakthrough](/topic/breakthrough), [surfing](/topic/surfing) ### Top Social Posts [#](/topic/$85114b/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Goldman analyst be needing ๐ $2.5B peak sales is 1k of 40k symptomatic of 100k HD patients $QURE early sales likely $2.5B & rise from there especially as many more get diagnosed once theres a breakthrough therapy like AMT-130. 3-5x mult gets you closer to $20B $XXX ps" [X Link](https://x.com/JD4for4/status/1977054534234259784) [@JD4for4](/creator/x/JD4for4) 2025-10-11T16:51Z 8291 followers, 8050 engagements "Exponential power of $CLPT & $QURE 1+1= XX $QURE was trading for cash just X year ago at around $XXX million cap now will probably be acquired for $XXXX Billion within next year. Thats a 30x in about X years ladies & gents. Now the crazy part: $CLPT is powering 50+ other trials. Attempting to put a valuation on that is futile or just sounds insane" [X Link](https://x.com/BostonDrei/status/1977041319387177350) [@BostonDrei](/creator/x/BostonDrei) 2025-10-11T15:59Z 1681 followers, 10.9K engagements "Great summary of gene therapy buyouts over the years showing buyout possibility for $QURE. My personal belief is he is conservative and it will happen for more $$ assuming they demonstrate positive TLE data 1st half of 2026 on more patients that is as good as patient #1" [X Link](https://x.com/DesertDweller93/status/1977030166938624034) [@DesertDweller93](/creator/x/DesertDweller93) 2025-10-11T15:14Z 3864 followers, 8839 engagements "Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside from current levels. Gene therapy companies don't stay independent long after pivotal data. The sector has a 5-year M&A track record showing consistent 88-215% premiums for CNS assets with breakthrough results especially in the 6-18 month pre-approval window. Here's what Novartis Roche Astellas and Biogen have paid for comparable assets and where $QURE sits in the cycle: Novartis / AveXis (2018 Zolgensma) ๐ฐ $8.7B +88% Premium ๐งช Stage: X months pre-BLA (Phase X complete) ๐ Peak Sales: $XX B (2024" [X Link](https://x.com/mikeaxolotl/status/1977026632981643313) [@mikeaxolotl](/creator/x/mikeaxolotl) 2025-10-11T15:00Z XXX followers, 41.8K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Crypto project sees positive social sentiment. Market volatility causes price fluctuations.
A cryptocurrency project.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1-Year High: XXXXX on 2025-10-15
1-Year Low: XXX on 2025-10-16
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-10-15
1-Year Low: X on 2025-10-15
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $85114b in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-10-15
1-Year Low: X on 2025-10-15
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XXX%
1-Year High: XXX% on 2025-10-15
1-Year Low: XXX% on 2025-10-15
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XX | XX% | X | X% |
Total | XXX | XX% | XX | XX% | X | X% |
Top assets mentioned In the posts about $85114b in the last XX hours
uniQure N.V. (QURE) Novartis AG (NVS)
Top topics mentioned In the posts about $85114b in the last XX hours
$qure, $clpt, upside, novartis, $novnsw, stocks healthcare, over the, half of, acquisition, power of, jordan, $25b, 100k, breakthrough, surfing
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Goldman analyst be needing ๐ $2.5B peak sales is 1k of 40k symptomatic of 100k HD patients $QURE early sales likely $2.5B & rise from there especially as many more get diagnosed once theres a breakthrough therapy like AMT-130. 3-5x mult gets you closer to $20B $XXX ps"
X Link @JD4for4 2025-10-11T16:51Z 8291 followers, 8050 engagements
"Exponential power of $CLPT & $QURE 1+1= XX $QURE was trading for cash just X year ago at around $XXX million cap now will probably be acquired for $XXXX Billion within next year. Thats a 30x in about X years ladies & gents. Now the crazy part: $CLPT is powering 50+ other trials. Attempting to put a valuation on that is futile or just sounds insane"
X Link @BostonDrei 2025-10-11T15:59Z 1681 followers, 10.9K engagements
"Great summary of gene therapy buyouts over the years showing buyout possibility for $QURE. My personal belief is he is conservative and it will happen for more $$ assuming they demonstrate positive TLE data 1st half of 2026 on more patients that is as good as patient #1"
X Link @DesertDweller93 2025-10-11T15:14Z 3864 followers, 8839 engagements
"Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside from current levels. Gene therapy companies don't stay independent long after pivotal data. The sector has a 5-year M&A track record showing consistent 88-215% premiums for CNS assets with breakthrough results especially in the 6-18 month pre-approval window. Here's what Novartis Roche Astellas and Biogen have paid for comparable assets and where $QURE sits in the cycle: Novartis / AveXis (2018 Zolgensma) ๐ฐ $8.7B +88% Premium ๐งช Stage: X months pre-BLA (Phase X complete) ๐ Peak Sales: $XX B (2024"
X Link @mikeaxolotl 2025-10-11T15:00Z XXX followers, 41.8K engagements
/topic/$85114b